An examination of the current state of pharmacovigilance and postmarketing surveillance programs in the United States and potential solutions for improvement
IO_a6ac78e5-952b-4698-8605-c1bd0193b0bc
Are current federal regulations on OTC drug products sufficient to control nation-wide methamphetamine issues?
IO_f3211026-20fa-44d3-8ff3-65e50f6b782c
Can China be a viable biosimilars entry market as compared with the US?
IO_e460dc8d-e98b-46f5-a4b7-95c325cdb99d
Mixed effects modeling of tranexamic acid in pediatric patients
IO_a30d17e0-4a19-40b0-aa6c-77516bb177df
Orphan drug market developments in the US and EU
IO_f7abfec1-6ad2-4c87-bad4-bca18517e304
Pediatric medicinal product research and development
IO_f4fefbef-1165-40a5-a71e-aef23400a447
We use cookies so that we can provide you with the best user experience possible. Click Accept to confirm that you are happy with us to use cookies.
